Generlac and Morphine sulfate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Generlac (lactulose) and Morphine sulfate (morphine sulfate). Common drug interactions include injection site bruising among females and emotional distress among males.

The phase IV clinical study analyzes what interactions people have when they take Generlac and Morphine sulfate. It is created by eHealthMe based on reports of 27 people who take the same drugs from the FDA, and is updated regularly.

What is Generlac?

Generlac has active ingredients of lactulose. It is often used in constipation. eHealthMe is studying from 657 Generlac users. Check the latest studies of Generlac.

What is Morphine sulfate?

Morphine sulfate has active ingredients of morphine sulfate. It is often used in pain. eHealthMe is studying from 87,261 Morphine sulfate users. Check the latest studies of Morphine sulfate.

On Jul, 15, 2026

27 people who take Generlac and Morphine sulfate together, and have interactions are studied.

Generlac and Morphine sulfate drug interactions.

What are the common drug interactions of Generlac and Morphine Sulfate, by gender? *:

female:

Injection site bruising
Injection site erythema (redness at injection site)
Injection site mass
Injection site pain
Injection site pruritus (severe itching at injection site)
Injection site reaction
Contusion (a type of hematoma of tissue in which capillaries)
Depression
Diarrhoea
Dizziness

male:

Emotional distress
Bone density decreased
Renal impairment (severely reduced kidney function)
Tooth loss
Nausea (feeling of having an urge to vomit)
Chronic kidney disease
Drug ineffective
Dyspnoea (difficult or laboured respiration)
Haematochezia (passage of stools containing blood)
Renal injury (kidney injury)

What are the common drug interactions of Generlac and Morphine Sulfate, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Injection site bruising
Injection site erythema (redness at injection site)
Injection site mass
Injection site pain
Injection site pruritus (severe itching at injection site)
Injection site reaction
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Bone density decreased
Emotional distress

50-59:

Chronic kidney disease
Drug ineffective
Fatigue (feeling of tiredness)
Hyperphagia (an abnormal appetite for food)
Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
Nausea (feeling of having an urge to vomit)
Non-alcoholic steatohepatitis (liver inflammation caused by a build up of fat in the liver)
Renal failure (kidney dysfunction)

60+:

Death
Renal failure (kidney dysfunction)
Vomiting
Nausea (feeling of having an urge to vomit)
Asthenia (weakness)
Emotional distress
Fall
Fatigue (feeling of tiredness)
Haemoglobin decreased
Mass

What are the existing conditions these people have? *

Hiv Infection: 6 people, 22.22%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 4 people, 14.81%
Cardiac Disorder: 3 people, 11.11%
Malignant Melanoma (skin cancer rises from melancytes): 2 people, 7.41%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 2 people, 7.41%

* Approximation only. Some reports may have incomplete information.

Do you take Generlac and Morphine sulfate?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously